Similarly, patients with dyslipidemia (44.46% vs. 36.93%, p = 0.023) and hypertension (46.47% vs. 37.43%, p = 0.008) had higher proportions of CD28−/CD8+ T cells in PBMC compared to patients with normal lipid levels or blood pressure (Figure 2H). This evidence concerns the gene CD8A and metabolic syndrome.